MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
95 hedge funds and large institutions have $200M invested in Merrimack Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 17 reducing their positions, and 13 closing their positions.
Holders
95
Holders Change
+6
Holders Change %
+6.74%
% of All Funds
3.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
43
Reduced
17
Closed
13
Calls
$213K
Puts
$239K
Net Calls
-$26K
Net Calls Change
-$137K
Top Buyers
1 |
1
Jennison Associates
New York
|
$20.7M |
2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$5.12M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$17.8M |
4 |
MF
4
Magnetar Financial
Evanston,
Illinois
|
$6.29M |
5 |
5
Northern Trust
Chicago,
Illinois
|
$4.98M |